Lack of effectiveness of the 23-valent polysaccharide pneumococcal vaccine in reducing all-cause pneumonias among healthy young military recruits: A randomized, double-blind, placebo-controlled trial
- 8 January 2015
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 33 (9), 1182-1187
- https://doi.org/10.1016/j.vaccine.2014.12.058
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or olderBMC Infectious Diseases, 2010
- Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: A matched case–control studyVaccine, 2009
- Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: Benefit due to influenza and pneumococcal vaccination not demonstratedVaccine, 2007
- Protective Effects of the 23‐Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN‐65 StudyClinical Infectious Diseases, 2006
- Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-upVaccine, 2003
- Role of Neuraminidase in Lethal Synergism between Influenza Virus andStreptococcus pneumoniaeThe Journal of Infectious Diseases, 2003
- Effectiveness of Pneumococcal Polysaccharide Vaccine for Preschool-Age Children with Chronic DiseaseEmerging Infectious Diseases, 1999
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineNew England Journal of Medicine, 1991
- Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within GroupsThe Journal of Infectious Diseases, 1983
- An Epidemic of Pneumococcus BronchopneumoniaThe Journal of Infectious Diseases, 1919